EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis

Autor: Driessen, MT, Krasenbaum, LJ, Ramirez-Campos, V, DiEgidio, R, Tian, M, Seminerio, MJ
Zdroj: In Value in Health July 2022 25(7) Supplement:S346-S346
Databáze: ScienceDirect